2 / 20
allied
academies
Virology Research Journal
Volume 1 Issue 4
Vaccines World 2017
Notes:
Page 34
November 09-10, 2017 Vienna, Austria
21
st
World Congress and Exhibition on
VACCINES, VACCINATION & IMMUNIZATION
Ethical issues in the production, design and clinical
trials of new vaccines for emerging diseases in low
income countries
Ida Cristina Gubert
Federal University of Parana, Brazil
S
ince first developed by Jenner and Pasteur vaccines have
shown to be an important tool for the eradication (cow pox)
and prevention of communicable diseases with high morbidity
and mortality rates, and became one component of public health
policies. However, good quality housing, appropriate disposal of
sewage, nutrition, education and adequate sanitary conditions
have also been an important determinant in health promotion.
In this way, upper level societies have witnessed a significant
reduction of diseases such as zoonosis, communicable diseases
and vector born infections. Nevertheless, populations in low
income countries still face poor sanitary and living conditions
which contribute to the emergence of new diseases. Recently
countries in Latin America witnessed the epidemics of a vector
borne viral infection that resulted in microcephaly to the
fetuses born from infected women. The purpose of this text is to
present a reflection on the life conditions of these populations,
their vulnerability, the need for new vaccines, the public health
policies to be implemented and the ethical issues to be considered
in this reality. An analysis on the ethical issues concerning the
development of new vaccines and their trials in low income
countries. It is undeniable all benefits that have been reached in
health promotion through immunization protocols worldwide.
However insufficient supply, the rationale of use and distribution
of vaccines in low income countries, the health condition of the
participants in the trials, inclusion and exclusion criteria, the
comparative arm, the inclusion of pregnant women, risks and
benefits, the availability of the final product once trial is finished
and the voluntary or compulsory character of immunization
are some of the ethical issues that deserve consideration in the
development and distribution of vaccines as a part of public
health policies in low income countries.
Biography
Ida Cristina Gubert completed her Bachelor degree in Biological Sciences from
Universidade Federal do Paraná (1975); Master’s Degree in Genetics from
Universidade Federal do Paraná (1986); PhD in Biochemical and Molecular
Pharmacology from Universidade Federal de Minas Gerais (2005) and; Post-
doc in Bioethics in Clinical Research (Facultad Latinoamericana de Ciências
Sociales, FLACSO, Argentina). She has experience in Immunology, focusing
on Applied Immunology.
gubert@ufpr.brIda Cristina Gubert, Virol Res J 2017, 1:4